|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 122.3 USD | +1.02% |
|
+4.13% | -12.18% |
| Apr. 22 | Bernstein Adjusts Price Target on Illumina to $129 From $150 | MT |
| Apr. 22 | Baird Adjusts Price Target on Illumina to $125 From $146, Neutral Rating Kept | MT |
Aug 9 (Reuters) - Illumina Inc lowered annual profit forecast on Wednesday, signaling weak demand for its sequencing and diagnostic services, sending the life sciences firm's shares down 7.5% after the bell.
The San Diego, California-based company expects full-year adjusted profit per share to be between $0.75 and $0.90, compared with its prior forecast of $1.25 to $1.50 per share.
(Reporting by Pratik Jain in Bengaluru; Editing by Shilpi Majumdar)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 573.6 USD | +0.33% | +5.29% | 219B | ||
| 246.6 USD | +0.32% | +4.70% | 183B | ||
| 122.3 USD | +1.02% | +4.13% | 19.47B | ||
| 0.000001 USD | 0.00% | 0.00% | 14 | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -12.18% | 19.47B | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
ILLUMINA, INC. 
